NCT00289510View on ClinicalTrials.gov

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

January 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Inactivated influenza vaccine (whole virion, Vero cell-derived)

BIOLOGICAL

Inactivated influenza vaccine (egg derived) [licensed control vaccine]

Trial Locations (3)

1090

Allgemeines Krankenhaus Wien (General Hospital Vienna), Vienna

14050

Klinikum Westend, Haus 18, Berlin

55116

Internistische Gemeinschaftspraxis Dr. Regner & Dr. Schmitt (Group practice for internal medicine), Mainz

All Listed Sponsors
lead

Alachua Government Services, Inc.

INDUSTRY

NCT00289510 - Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) | Biotech Hunter | Biotech Hunter